Stockreport

Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing

Invizyne Technologies Inc.  (IZTC) 
PDF Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufa [Read more]